These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25812756)

  • 41. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation.
    van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH
    Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of peripheral arterial disease using stem and progenitor cell therapy.
    Lawall H; Bramlage P; Amann B
    J Vasc Surg; 2011 Feb; 53(2):445-53. PubMed ID: 21030198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Stem Cells Overexpressing miR-21 Promote Angiogenesis in Critical Limb Ischemia by Targeting CHIP to Enhance HIF-1α Activity.
    Zhou Y; Zhu Y; Zhang L; Wu T; Wu T; Zhang W; Decker AM; He J; Liu J; Wu Y; Jiang X; Zhang Z; Liang C; Zou D
    Stem Cells; 2016 Apr; 34(4):924-34. PubMed ID: 26841045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization].
    Kalka C; Asahara T; Krone W; Isner JM
    Herz; 2000 Sep; 25(6):611-22. PubMed ID: 11076319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiogenesis and gene therapy in man: dream or reality?
    Amant C; Berthou L; Walsh K
    Drugs; 1999; 59 Spec No():33-6. PubMed ID: 10548390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
    Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S
    J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Intramuscular Administration of Mesenchymal Stem Cells and Erythropoietin on Angiogenesis in Critical Limb Ischemia.
    Lykov AP; Bondarenko NA; Poveshchenko OV; Kabakov AV; Surovtseva MA; Kim II; Kazakov OV; Poveshchenko AF
    Bull Exp Biol Med; 2018 May; 165(1):121-126. PubMed ID: 29796803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in growth factor delivery for therapeutic angiogenesis.
    Said SS; Pickering JG; Mequanint K
    J Vasc Res; 2013; 50(1):35-51. PubMed ID: 23154615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell therapy in critical limb ischemia: current developments and future progress.
    Mamidi MK; Pal R; Dey S; Bin Abdullah BJ; Zakaria Z; Rao MS; Das AK
    Cytotherapy; 2012 Sep; 14(8):902-16. PubMed ID: 22731756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia.
    Deev RV; Bozo IY; Mzhavanadze ND; Voronov DA; Gavrilenko AV; Chervyakov YV; Staroverov IN; Kalinin RE; Shvalb PG; Isaev AA
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):473-82. PubMed ID: 25770117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials.
    Furmston J; Patel AS; Ludwinski F; Zuzel V; Bajwa A; Saha P; Smith A; Modarai B
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):641-54. PubMed ID: 24941243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells].
    Di Stefano R; Limbruno U; Barone D; Balbarini A
    Ital Heart J Suppl; 2004 Jan; 5(1):1-13. PubMed ID: 15253139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy in vascular disease.
    Sedighiani F; Nikol S
    Surgeon; 2011 Dec; 9(6):326-35. PubMed ID: 22041646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiogenic gene therapy: pre-clinical studies and phase I clinical data.
    Bashir R; Vale PR; Isner JM; Losordo DW
    Kidney Int; 2002 Jan; 61(1 Suppl):S110-4. PubMed ID: 11841623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beperminogene perplasmid for the treatment of critical limb ischemia.
    Suda H; Murakami A; Kaga T; Tomioka H; Morishita R
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1145-56. PubMed ID: 25190335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
    Perin EC; Silva G; Gahremanpour A; Canales J; Zheng Y; Cabreira-Hansen MG; Mendelsohn F; Chronos N; Haley R; Willerson JT; Annex BH
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1060-7. PubMed ID: 21594960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.
    Flugelman MY; Halak M; Yoffe B; Schneiderman J; Rubinstein C; Bloom AI; Weinmann E; Goldin I; Ginzburg V; Mayzler O; Hoffman A; Koren B; Gershtein D; Inbar M; Hutoran M; Tsaba A
    Mol Ther; 2017 Mar; 25(3):816-825. PubMed ID: 28143739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The angiogenic effects of ischemic conditioning in experimental critical limb ischemia.
    Karakoyun R; Koksoy C; Yilmaz TU; Altun H; Banli O; Albayrak A; Alper M; Sener Z
    Eur J Vasc Endovasc Surg; 2014 Feb; 47(2):172-9. PubMed ID: 24333045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic angiogenesis for critical limb ischemia: invited commentary.
    Messina LM; Brevetti LS; Chang DS; Paek R; Sarkar R
    J Control Release; 2002 Jan; 78(1-3):285-94. PubMed ID: 11772469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.